A 39-year-old man with recurrent epileptic seizures presents to his primary care physician for follow-up. He has no pertinent past medical, surgical, or family history in relation to his seizures. CT scan of the head reveals normal cerebral and cerebellar structures. There is no evidence of hydrocephalus. What is the most likely explanation of this patient's seizures?

Questions 144

ATI RN

ATI RN Test Bank

Pharmacology of CNS Drugs Questions

Question 1 of 5

A 39-year-old man with recurrent epileptic seizures presents to his primary care physician for follow-up. He has no pertinent past medical, surgical, or family history in relation to his seizures. CT scan of the head reveals normal cerebral and cerebellar structures. There is no evidence of hydrocephalus. What is the most likely explanation of this patient's seizures?

Correct Answer: C

Rationale: In this case, the most likely explanation for the patient's seizures is idiopathic (Option C). Idiopathic seizures refer to seizures with no identifiable cause, which is the scenario presented in this patient's history and investigations. Alcohol-induced seizures (Option A) would typically require a history of alcohol abuse, which is not mentioned in the patient's history. Iatrogenic causes (Option B) would involve medication or medical treatment as the trigger for the seizures, which is not indicated in the scenario. Neoplastic causes (Option D) would involve the presence of a brain tumor, which is ruled out by the normal CT scan findings. From an educational perspective, understanding the term idiopathic is crucial in clinical practice. It highlights the importance of thorough history-taking, investigations, and the consideration of various differential diagnoses in managing patients with seizures. This case underscores the need for a comprehensive approach to diagnosing and managing epilepsy, especially when an obvious cause is not immediately apparent.

Question 2 of 5

A 29-year-old woman who has been diagnosed with multiple sclerosis presents to her primary care physician with muscle rigidity and spasms. She also complains of difficulty sleeping, heartburn, and muscle pain. One of the drugs her physician prescribes is baclofen. Which of the following will baclofen do for this patient?

Correct Answer: C

Rationale: Rationale: Baclofen is a centrally acting skeletal muscle relaxant commonly used to treat muscle spasticity, including muscle rigidity and spasms. In the case of the 29-year-old woman with multiple sclerosis presenting these symptoms, baclofen is prescribed to relieve her muscle spasms. Option A, anti-inflammatory to decrease muscle pain, is incorrect because baclofen primarily acts on the nervous system to reduce muscle spasticity, not inflammation. Option B, decrease heartburn, is incorrect as baclofen's primary action is not related to the gastrointestinal system. Option D, reverse the progression of MS, is incorrect because while baclofen may help manage symptoms associated with MS, it does not alter the course of the disease or its progression. Educationally, understanding the mechanism of action of drugs is crucial in pharmacology. Baclofen's role in treating muscle spasms by acting on the central nervous system GABA receptors is a fundamental concept in CNS pharmacology. This knowledge helps healthcare providers make informed decisions in selecting appropriate treatments for patients based on their symptoms and underlying conditions.

Question 3 of 5

A 29-year-old man with spinal cord injury and with chronic gastric immotility syndrome has failed therapy with numerous cholinoimimetic agents. He has begun on therapy with physostigmine. Unfortunately, a supratherapeutic dose is administered to the patient. Which of the following effects must the treating physician be aware of?

Correct Answer: A

Rationale: The correct answer is A) Convulsions. Physostigmine, a cholinesterase inhibitor, can lead to excessive cholinergic stimulation when given in supratherapeutic doses. This can result in overstimulation of the CNS, leading to convulsions. Option B) Flaccid paralysis is incorrect because cholinesterase inhibitors like physostigmine typically cause muscle contractions rather than paralysis. Option C) Pulmonary embolism is unrelated to the pharmacological effects of physostigmine. Option D) Sinus tachycardia is unlikely with physostigmine overdose as it primarily affects the cholinergic system, not the cardiac system. Educationally, this question highlights the importance of understanding the pharmacological mechanisms of CNS drugs and the potential adverse effects of cholinesterase inhibitors. It emphasizes the need for precise dosing and monitoring to prevent harmful outcomes in patients, especially those with pre-existing conditions like spinal cord injury and gastric motility issues.

Question 4 of 5

A 68-year-old man with a 6-month history of progressive pill-rolling tremors of the hands, urinary incontinence, and cogwheel rigidity presents to his primary care physician for evaluation. Physical examination confirms the earlier findings. Which of the following is a therapeutic goal for this condition?

Correct Answer: A

Rationale: In this scenario, the correct answer is A) Antagonizing the excitatory effect of cholinergic neurons. The patient is presenting with symptoms suggestive of Parkinson's disease, a neurodegenerative disorder characterized by a deficiency of dopamine in the brain. Antagonizing the excitatory effect of cholinergic neurons can help rebalance the neurotransmitter levels in the brain by reducing the overactivity of acetylcholine, which is elevated in Parkinson's disease. Option B) Dynamic physical and occupational therapy, while beneficial for improving mobility and quality of life in Parkinson's patients, does not address the underlying neurotransmitter imbalance in the brain. Option C) Lower concentrations of CNS dopamine is contrary to the therapeutic goal in Parkinson's disease, where the primary issue is a deficiency of dopamine. Option D) Restore dopamine concentration in the cerebellum is not accurate as Parkinson's disease primarily affects the substantia nigra in the brain, not the cerebellum. Educationally, it is crucial to understand the pathophysiology of Parkinson's disease and the role of neurotransmitters like dopamine and acetylcholine in motor function. Pharmacological interventions aim to restore the balance of these neurotransmitters to alleviate symptoms and slow disease progression. Understanding the rationale behind each treatment option is essential for providing effective care to patients with neurological disorders like Parkinson's disease.

Question 5 of 5

A 60-year-old man presents to his primary care physician for a new patient appointment. He is taking several drugs for his medical conditions. One of his medical conditions is hypertension, for which he takes a drug that acts on \(\alpha_2\)-receptors to lower blood pressure. Which of the following drugs is this?

Correct Answer: A

Rationale: The correct answer is A) Clonidine. Clonidine is a centrally acting alpha-2 adrenergic agonist that works by stimulating alpha-2 receptors in the brain, resulting in decreased sympathetic outflow from the central nervous system. This leads to vasodilation and a reduction in peripheral vascular resistance, ultimately lowering blood pressure. Option B) Metoprolol is a beta-blocker that acts on beta-adrenergic receptors, not alpha-2 receptors, to lower blood pressure by reducing heart rate and cardiac output. Option C) Reserpine is a drug that depletes catecholamines from storage vesicles, leading to decreased sympathetic activity but not specifically through alpha-2 receptor stimulation. Option D) Scopolamine is an anticholinergic drug used for motion sickness and nausea, not for lowering blood pressure. Understanding the pharmacological mechanisms of different classes of drugs is crucial in clinical practice to make informed decisions regarding drug selection, dosage, and monitoring for potential adverse effects. In this case, knowing that clonidine acts on alpha-2 receptors specifically helps in managing hypertension effectively in this patient.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions